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The potential alterations to structure and associations with thin filament proteins caused
by the dilated cardiomyopathy (DCM) associated tropomyosin (Tm) mutants E40K and
E54K, and the hypertrophic cardiomyopathy (HCM) associated Tm mutants E62Q and
L185R, were investigated. In order to ascertain what the cause of the known functional
effects may be, structural and protein-protein interaction studies were conducted utilizing
actomyosin ATPase activity measurements and spectroscopy. In actomyosin ATPase
measurements, both HCM mutants and the DCM mutant E54K caused increases in
Ca2+-induced maximal ATPase activities, while E40K caused a decrease. Investigation
of Tm’s ability to inhibit actomyosin ATPase in the absence of troponin showed that
HCM-associated mutant Tms did not inhibit as well as wildtype, whereas the DCM
associated mutant E40K inhibited better. E54K did not inhibit the actomyosin ATPase
activity at any concentration of Tm tested. Thermal denaturation studies by circular
dichroism and molecular modeling of the mutations in Tm showed that in general, the
DCM mutants caused localized destabilization of the Tm dimers, while the HCM mutants
resulted in increased stability. These findings demonstrate that the structural alterations
in Tm observed here may affect the regulatory function of Tm on actin, thereby directly
altering the ATPase rates of myosin.
Keywords: tropomyosin structure, cardiomyopathy, circular dichroism, thermal denaturation, actomyosin ATPase,
molecular modeling
INTRODUCTION
Numerous mutations in the proteins of the sarcomere have been
associated with cardiomyopathies (Chang and Potter, 2005; Force
et al., 2010; Seidman and Seidman, 2011; Hershberger et al.,
2013). Various studies of cardiomyopathic mutations suggest
distinct mechanisms for the progression of the dilated cardiomy-
opathic (DCM) and hypertrophic cardiomyopathic (HCM) phe-
notypes (Chang et al., 2005; Robinson et al., 2007; Willott et al.,
2010). An understanding of the disease progression necessitates
the study of the effects of the mutations on protein structure
and function (Force et al., 2010; Tardiff, 2011). One of the
sarcomeric proteins found to have mutations associated with car-
diomyopathies is cardiac α-tropomyosin (Tm) (Redwood and
Robinson, 2013). Tm is a semi-flexible rod-like protein whose
coiled-coil structure functions to control myosin interaction sites
on actin (Perry, 2001). Troponin (Tn) confers Ca2+ sensitivity
to this function (Holroyde et al., 1980; Farah and Reinach, 1995;
Gordon et al., 2000). Putative actin on/off regions along the
Abbreviations: wild-type human α-striated tropomyosin with and N-terminal
Ala-Ser dipeptide replacing the acetyl group (ASWT); DCM, dilated cardiomyopa-
thy; HCM, hypertrophic cardiomyopathy; Tm, tropomyosin; Tn, troponin.
length of Tm have been known for some time (McLachlan and
Stewart, 1976), and more recent studies of these regions have
demonstrated that although the length of the Tm dimer is com-
posed of regular turns which correspond to seven actin binding
regions, those regions are not all equal in terms of structure
and contribution to thin filament function (Phillips et al., 1986;
Hammell and Hitchcock Degregori, 1997; Landis et al., 1997,
1999; Singh and Hitchcock-Degregori, 2003; Barua et al., 2013).
How a single point mutation out of 284 amino acids in Tm
can lead to cardiomyopathies is an interesting question which
this paper attempts to understand, through the study of four
mutations, the DCM associated mutations E40K and E54K, and
the HCM associated mutations E62Q and L185R. All of these
mutations were previously identified from patients who pre-
sented severe cardiomyopathy (Olson et al., 2001; Van Driest
et al., 2002; Jongbloed et al., 2003). Previous investigation on
the effects of these HCM and DCM mutations by myofibrillar
ATPase measurements showed an increase in Ca2+ sensitivity for
HCM and a decrease in Ca2+ sensitivity for DCM associated
mutations, which is commonly found in mutations of the thin
filament associated with these diseases (Chang et al., 2005). In
addition, a decrease in inhibition of ATPase activity at low Ca2+
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concentrations were reported for the HCM associated mutations;
while DCM associated mutations had no significant effect on
inhibition, suggesting that distinct mechanisms, at the thin fila-
ment level, may underlie the different disease phenotypes (Chang
et al., 2005). The causes of the distinct functional effects pre-
viously reported are unknown, and while semi-“intact” systems
such as reconstituted myofibrils provide important mechanistic
information, there are toomany variables to identify the causative
perturbation.
Reconstituted fiber studies have shown distinct changes in
actin binding properties and actomyosin interactions linked to
altered movement of Tm on actin caused by DCM associated
mutations E40K and E54K (Borovikov et al., 2009b,c; Bai et al.,
2012). Results of such studies have led to conclusions that dis-
tinct mutations cause defects in contraction via mechanisms
unique to the mutations (Borovikov et al., 2009a,b,c; Bai et al.,
2012). Reconstituted fibers are complex intact systems in which
the components of the thin filament are completely replaced
with exogenous proteins. More recently, energy landscape studies
have shown that mutations in Tm linked to HCM are asso-
ciated with a decrease in actin–Tm interaction energy, which
is thought to impair the relaxation properties of the thin fil-
ament (Orzechowski et al., 2014). However, using the same
technique, mutations in Tm linked to DCM do not seem to
enhance actin-Tm interaction (Orzechowski et al., 2014). Due
to the complexity of the system, here we aimed to under-
stand the effects of the mutations on Tm’s interactions with
its functional partner proteins by actomyosin ATPase activity
assays and on the helical stability of Tm dimers. Unlike recon-
stituted myofibrillar or fiber preparations, actomyosin ATPase
activity assays were performed with purified actin, myosin,
Tm and Tn. By titrating Tm and Tn into actin and myosin
mixtures, we sought to identify the specific protein-protein
interaction affected by the abovementioned point mutations in
Tm. Results of these studies pointed toward the possibility of
effects of the mutations on Tm dimer interactions, which have
the potential for long-range effects on myofilament function.
The structural effects of the mutations were further dissected
through thermal denaturation studies and energy minimization
studies.
MATERIALS AND METHODS
EXPRESSION AND PURIFICATION OF RECOMBINANT TMS AND TNS
Recombinant Tm and Tns were expressed and purified utilizing
previously described methods (Chang et al., 2005). Alanine-
Serine were added to the N-terminus of all Tm proteins to mimic
acetylation as previously described (Urbancikova and Hitchcock-
Degregori, 1994), and is referred to as “ASWT” in figures.
Human cardiac Tn complexes comprised of recombinant TnT,
TnI, and TnC were prepared by sequential dialysis in decreasing
concentrations of urea and KCl (Gomes et al., 2002).
THERMAL DENATURATION STUDIES BY CIRCULAR DICHROISM (CD)
Far-UV CD spectra were collected using a 1-mm-path quartz
cell in a Jasco J-720 spectropolarimeter. The measurements were
obtained using pure recombinant proteins which were dialyzed
in 10mM sodium phosphate buffer pH 7.0, 150mM sodium
fluoride, and diluted to 0.1mg/mL. Thermal denaturation
measurements were obtained with proteins which had been
diluted to 0.1mg/mL, at 222 nm over a range of temperatures
(20–60◦C). Melting temperatures were determined by fitting
the mean residue ellipticity, [θ]222, to a two-state or three-
state transition model as previously described (Greenfield and
Hitchcock-Degregori, 1995; Greenfield, 2006). See description for
the three-state transition model below:
θobserved = 1α1 + 2α2 + 2α2 (1)
where
α1 = K1
1 + K1 , α2 =
K2
1 + K2 , and
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H1, H2, andH3 are the respective enthalpies of folding of
the first, second, and third transitions at the lowest to highest
temperature. TM1, TM2, and TM3 are the observed midpoints of
each transition. ∈1, ∈2, ∈3 are the extinction coefficients for the
circular dichroism change associated with each transition, and
[C] is the concentration of the Tm dimer in mole/L. The initial
values of H and TM were estimated and the unfolding equa-
tions were fit using SigmaPlot 11.0 (Greenfield, 2006). The ASWT
and L185R were fit using a two-state transition model, while the
other mutants were fit using a three-state transition model as
determined by the correlation coefficient (Greenfield, 2006).
PURIFICATION OF RABBIT SKELETAL ACTIN
Skeletal actin was purified from the longissimus dorsi and psoas
muscles of female New Zealand White rabbits, utilizing rou-
tine methods established in the lab, according to the procedure
described by Strzelecka-Golaszewska et al. (1975) and Pardee and
Spudich (1982).
PURIFICATION OF PORCINE CARDIAC MYOSIN
Cardiac myosin was purified from the left ventricles of hearts
from freshly sacrificed pigs, by a method routinely utilized in
the lab (Szczesna et al., 2000), based on the original procedure
described by Murakami et al. (1976).
ACTOMYOSIN ATPase ASSAYS
Porcine cardiac myosin, rabbit skeletal actin and human cardiac
Tm and Tns were homogenized to a final concentration of 0.6μM
myosin, 3.5μM actin, 1μM Tm, and 0–1.5μM Tn in ATPase
assay buffer (40mM KCl, 15mM MOPS pH 7.0, 3.5mM MgCl2,
1mM DTT, 1mM EGTA (pCa 9.5) or 0.416mM CaCl2 (pCa 4).
For Tm titration studies, Tm was varied from 0 to 1.5μM, in the
absence of Tn. ATPase reactions were initiated with the addition
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of ATP to a final concentration of 2.9mM, the amount calculated
to yield approximately 1mM free MgCl2 (Dweck et al., 2005).
ATPase assays were performed at 37◦C for 20min and the reaction
was stopped with the addition of 25μL of 35% trichloroacetic
acid. The amount of inorganic phosphate released during the
ATPase assays was determined by use of the Fiske-Subbarrow
reagent (Fiske and Subbarrow, 1925).
STATISTICAL ANALYSIS
For all measurements, significance of comparison to ASWT was
determined by 1- or 2-way ANOVA followed by Dunnett’s mul-
tiple comparisons test against ASWT. In all figures significance is
denoted as follows: ∗p < 0.05, †p < 0.01, ‡p < 0.001.
MUTANT TMMODELING
To model the effects of the E40K, E54K, and E62Q mutations,
the structure of a fragment of Tm containing residues 1–80, pdb
accession number 1IC2 were used as a starting point (Brown
et al., 2001). To model the effect of the mutation L185R the X-ray
structure of a mid-region fragment of Tm, pdb accession num-
ber 2B9C was used as a starting point (Brown et al., 2005). In
all cases, the point mutations were introduced into the respective
crystal structures, hydrogens and Gastiger- Huckel charges were
added to the structure, and the structures were then minimized
with unrestrained helices to convergence using the program Sybyl
(Tripos Associates). The molecular graphics images were pro-
duced using the UCSF Chimera package from the Computer
Graphics Laboratory, University of California, San Franscisco
(Pettersen et al., 2004) supported by National Institutes of Health
grant P41 RR-01081.
RESULTS
EFFECTS OF MUTATIONS ON TN CONCENTRATION DEPENDENT
ACTIVATION AND INHIBITION OF ACTOMYOSIN ATPase ACTIVITY
To investigate the effects of the mutations on actin-myosin inter-
action and thin filament regulation of ATPase activity, the actin
and myosin concentrations were held constant and the effects of
increasing concentrations of Tn on actomyosin ATPase rates were
measured. As a control for the assay, a well-characterized HCM
mutation E180G was also included in the actomyosin ATPase
assays. The results of these studies show that the two DCM
mutants gave strikingly different results where E40K causes a sig-
nificant decrease in maximal ATPase activity and E54K causes an
increase (Figure 1A). Increased rates over ASWT were measured
at high [Ca2+] for all three HCMmutants (Figure 1A).
In all assays, ATPase rates reached a maximum by 1μM Tn.
Therefore, relative maximal actomyosin ATPase rates of DCM
(Figure 1B) and HCM (Figure 1C) mutant Tm samples in high
and low [Ca2+] at 1μM Tm and 1–1.5μM Tn, were plotted to
better illustrate the [Ca2+]-dependent trends. When normalized
to ASWT in high [Ca2+], the rate at low [Ca2+] is 8.5 ± 0.3%.
Consistent with plots in Figure 1A, the maximal rates for E40K
in high and low [Ca2+] were lower: 85 ± 1.8% and 7.1 ± 0.1%,
respectively. The maximal rates for E54K in high and low [Ca2+]
were higher: 122 ± 3.8% and 9.9 ± 0.4%, respectively. All HCM
associated mutants showed significantly increased rates in high
[Ca2+], of 122 ± 1.7% for E62Q, 112 ± 2.9% for E180G, and
117 ± 2.1% for L185R. In low [Ca2+], all but E62Q had sig-
nificantly increased rates: 8.7 ± 0.3% for E62Q, 12 ± 0.5% for
E180G, and 11 ± 0.5% for L185R.
In addition to the differences in maximal Ca2+-dependent
activity, the rates in the absence of Tn vary significantly for some
mutants, suggesting that Tm alone is affecting the actomyosin
ATPase rate (Figure 1A). In the absence of Tn, the actomyosin
ATPase activity is not Ca2+-dependent. Comparison of averaged
baseline values in the absence of Tn showed that the ATPase activ-
ity in mol Pi/mol myosin/sec was 0.27 ± 0.01 for ASWT, and
significantly lower at 0.23 ± 0.1 for E40K. The baseline activ-
ity was significantly higher for E54K and E62Q, which were both
0.32 ± 0.1. The baseline activity differences were not statistically
significant for E62Q and E180G, which were 0.28 ± 0.02 and
0.30 ± 0.01.
EFFECTS OF THE MUTATIONS ON THE TM CONCENTRATION
DEPENDENT INHIBITION OF ACTOMYOSIN ATPase ACTIVITY
Increasing the concentration of Tm is known to result in dimin-
ished actomyosin ATPase activity, when themyosin concentration
is held low and constant (Lehrer andMorris, 1982). To gain infor-
mation on the possible effects of the mutations on Tm binding
to actin and consequently, inhibition of actin-myosin interac-
tions, actomyosin ATPase rates were measured at low [Ca2+]
conditions with increasing amounts of Tm, in the absence of
Tn (Figure 2A). Comparison of the Tm concentration dependent
inhibition showed that E40K inhibited actomyosin ATPase activ-
ity better than ASWT, while E54K did not inhibit the actomyosin
ATPase activity at all (Figure 2A). HCM associated mutants
did not inhibit the actomyosin ATPase activity over ASWT,
except the E62Q which increased the actomyosin ATPase activity
(Figure 2A). Ratios of protein mixtures for ASWT and mutants
were confirmed by Coomassie gel analysis (Figure 2B) and activ-
ity rates at 1μM Tm compared for all mutants (Figure 2C).
Consistent with trends seen in the Tm titration studies, and the
baseline rate differences measured in the Tn titration studies, the
rates with 1μM Tm are significantly lower in E40K and signif-
icantly higher in E54K and E62Q mutants. The rates of E180G
and L185R are increased but not significantly.
EFFECTS OF MUTATIONS ON TM STRUCTURE
The effects of the mutations investigated by CD spectra mea-
surements showed that the single point mutations do not have
significant effects on the mean residue ellipticity of Tm. Minor
differences were seen, but are not significant (data not shown).
Further investigation of the effects of the mutations on Tm struc-
ture by thermal denaturation showed interestingly, that the point
mutations have differential effects on the melting transitions of
Tm (Figure 3A). The individual denaturation curves were fitted
to a three-transition model to identify the melting transition tem-
peratures, the enthalpy change associated with unfolding and the
fraction of the change in ellipticity due to each transition. The val-
ues are summarized in Table 1. In three of the cases, the results of
the mutations caused the appearances of an additional transition,
suggesting that the changes were local, and affecting a relatively
small portion of the Tm molecule (Figure 3B, Table 1). To assess
the effects of the mutations on Tm stability, TM50 values were
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FIGURE 1 | Effects of DCM and HCM Tm mutants on Tn concentration
dependent actomyosin ATPase activity. (A) The Tn concentration-
dependent ATPase rates of actomyosin samples prepared with ASWT and
mutant Tms were compared. Tn was titrated from 0 to 1.5μM into mixtures
of 0.6μM myosin, 3.5μM actin, and 1μM Tm, and the actomyosin ATPase
activation at high (pCa 4) [Ca2+] (up-sloping) and inhibition at low (pCa 9.5)
[Ca2+] (down-sloping) were measured for DCM (upper panel) and HCM
(lower panel) associated mutations. The results represent the mean ± SE of
calculated activity rates of experiments (n = 5) performed in triplicate.
Samples graphed on DCM panel: ASWT (filled circle), E40K (filled square),
E54K (filled triangle); on HCM panel: ASWT (filled circle), E62Q (open
diamond), E180G (open square), L185R (open triangle). The maximal ATPase
activity values of ASWT and DCM-associated (B) and HCM-associated
(C) mutant Tm reconstituted actomyosin solutions in low (pCa 9.5; filled bar)
and high (pCa 4; open bar) [Ca2+] were compared. Relative rates shown
graphed are a percentage of the mean high [Ca2+] activated ASWT rate
obtained from mixtures of 0.6μM myosin, 3.5μM actin, 1μM Tm, and
1–1.5μM Tn. Mean percentages ± SE were graphed; n = 20. Statistical
significance were determined by ANOVA followed by Dunnett’s multiple
comparisons test; ∗p < 0.05, †p < 0.01, ‡p < 0.001.
calculated from the thermal denaturation curves of ASWT and
mutants. The TM50 values show shifts temperatures suggestive of
decreased stability for the DCM E40K mutant and increased sta-
bility for E62Q and L185R (Figure 3C). The stability for the E54K
mutant did not change compared to ASWT (Figure 3C, Table 1).
Changes in Tm stability were explored through energy mini-
mized models of the Tm mutations, which gives insight into the
potential effects at the dimer interface (Figure 4). The heptad
repeat position of the native protein residues and the expected
interactions within the Tm molecule interface has been described
in detail (Brown and Cohen, 2005). In the native protein, E40
in position e has a strong inter-chain interaction with R35
in position g, where the carboxyl group of E40 can interact
with the amine side-chains of R35 (Brown et al., 2001, 2005).
Destabilization of the coiled-coil by E40K is observed. In addition,
E54 displays an intra-chain i to i+3 interactions with K51 and an
inter-chain interaction with K49 in position g. Destabilization of
the coiled-coil by E54K mutation is observed. Mutation of E62
to glutamine would not disrupt its interaction with K59 since
the two could still form a strong hydrogen bond, and would
allow interaction of the amide nitrogen with the carboxyl of D58,
which could result in stabilization of the molecule. However, the
carboxyl groups of E62 (carbon atoms in cyan) have intra-chain
interactions with the amine groups of K65 (carbon atoms in
magenta). When the E62 is mutated to Q, additional interactions
occur; the carboxyl group of the amide side-chain of Q62 can
still interact with the amine side-chain of K65 and the carboxyl
groups of D58 (carbon atoms in coral) can now hydrogen bond to
the amide hydrogens of the Q62 side chain. L185 is a hydropho-
bic residue that is exposed to the solvent and does not have any
close inter- or intra-chain interactions. The side-chains of L185
and R185 do not interact with K189 (carbon atoms in magenta),
but when L185 (carbon atoms in cyan) is mutated to R, it loses the
entropic penalty of having a hydrophobic residue exposed to the
solvent, and the basic side-chain can interact with the carboxyl
groups of E181 (carbon atoms in coral), stabilizing the molecule.
DISCUSSION
The data presented here reports on the effects of various car-
diomyopathy associatedmutations on Tm structure and function.
In the investigation of the effects of the mutations on Tn-
dependent activation and inhibition of actomyosin ATPase activ-
ity, the results show that the effects of the HCM-associated muta-
tions on the thin filament segregate well with disease, increasing
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FIGURE 2 | Effects of DCM and HCM-associated mutations on
Tm-dependent inhibition of actomyosin ATPase activity. (A) The
effects of Tm concentration dependent inhibition of actomyosin ATPase
activity were compared between ASWT and DCM (upper panel) and
HCM (lower panel) associated mutants. Tm was titrated from 0 to
1.5μM into solutions of 0.6μM myosin and 3.5μM actin, in low Ca2+
(pCa 9.5) buffer, and the actomyosin ATPase activity measured. The
results represent mean ± SE of activity rates normalized to the
maximum ATPase activity at 0μM Tm. All samples were measured in
triplicate; n = 5. Samples graphed on DCM panel: ASWT (filled circle),
E40K (filled square), E54K (filled triangle); on HCM panel: ASWT (filled
circle), E62Q (open diamond), E180G (open square), L185R (open
triangle). (B) Coomassie stained SDS-PAGE analysis of Tm titration study
samples. Samples taken from actomyosin ATPase activity assay mixtures
(0.6μM myosin, 3.5μM actin, 1μM Tm) were run on a 12% SDS-PAGE
gel, to confirm purity and proper ratios of proteins utilized in the Tm
titration studies. (C) Comparison of relative ATPase rates in the presence
of 1μM Tm. All samples were measured in triplicate; n = 16. Statistical
significance were determined by ANOVA followed by Dunnett’s multiple
comparisons test; ∗p < 0.05, †p < 0.01, ‡p < 0.001.
maximal actomyosin ATPase rates (Figure 1C), as previously
reported by myofibrillar ATPase assays (Chang et al., 2005).
Structurally, the position of the HCM-associated mutation E62Q
is an actin binding site residue (Phillips et al., 1986), and energy
minimized structural models predicted an increase in Tm dimer
stability, which is confirmed by the thermal denaturation study
presented here (Figure 3C). Due to its position in the Tm coiled-
coil, E62 does not have any inter-chain interactions in either the
WT or mutant proteins. The position of the HCM-associated
mutation L185R is also a consensus actin binding residue, and
is in a region of Tm found to be critical for actin binding and reg-
ulation (Greenfield et al., 2002; Singh and Hitchcock-Degregori,
2006). Although there are local stability changes associated with
E62Q which are not seen in L185R (Figure 3B), both muta-
tions caused increases in overall stability of the Tm molecule
(Figure 3C). Energy minimized model of the L185R mutant
structure suggests the reason for stabilization of Tm consistent
with increased TM50 of thermal denaturation (Figure 3C).
Consistent with our findings, several studies have reported
that changes in Tm stability and consequently disinhibition of the
myofilament at low [Ca2+] and increasing the number of active
crossbridges is one of the mechanisms by which Tm mutations
associated with HCM may induce diastolic dysfunction (Li et al.,
2012; Ly and Lehrer, 2012). In terms of clinical manifestation,
both HCM associated mutations were found in families which
were greatly affected by the mutation as demonstrated by the seg-
regation studies (Van Driest et al., 2002; Jongbloed et al., 2003).
The L185R mutation has only been investigated by our group
(Chang et al., 2005), and the recent identification of this muta-
tion in several members of another family with HCM, including
an 8-year-old girl who had sudden cardiac death (Makhoul et al.,
2011), underscores the need for characterization of the molecular
mechanisms affected by Tm mutations.
When the effects of themutations aremeasured bymyofibrillar
ATPase assays, both DCM-associated mutations E40K and E54K
had no effect on the inhibition of ATPase activity (Chang et al.,
2005). Examination of the current Tn titration study shows that
the baseline rates in the absence of Tn are different from ASWT
for E40K and E54K (Figure 1A). While E40K has diminished
activity in low [Ca2+], E54K has a slight increase (Figure 1B), in
agreement with the results of the Tm titration study (Figure 2C).
The highly increased inhibition of actomyosin activity by E40K
and total lack of inhibition by E54K (Figure 2A), is suggestive of
distinct mechanisms by which these two mutations cause DCM.
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FIGURE 3 | Thermal denaturation spectra of ASWT and mutants.
(A) Purified Tms were denatured by increasing the temperature from 20
to 60◦C, and the changes in ellipticity measured at each 0.2◦C. Each
spectra represents averaged mean residue ellipticity (MRE) of n = 9.
(B) Thermal transition temperatures obtained from fitting the
denaturation spectra to three transition models are shown as mean
values ±s.e.m. (C) Half maximal denaturation temperatures for ASWT
and mutants are shown as mean values ±s.e.m. Statistical significance
were determined by ANOVA followed by Dunnett’s multiple comparisons
test; ∗p < 0.05, †p < 0.01, ‡p < 0.001.
Furthermore, the in vitro data for the E54K mutation correlate
well with the in vivo phenotype reported in a transgenic mouse.
The transgenic mice expressing the Tm E54K mutation demon-
strated impaired systolic and diastolic functions (Rajan et al.,
2007). The decreased Ca2+ sensitivity of the myofilament can be
associated with the systolic dysfunction, while an inability of the
heart to relax correlates with the solutions studies where the E54K
does not inhibit the actomyosin ATPase (Figure 2A). This result
does not agree with general findings reported for DCM-associated
thin filament mutations, such as decreased Ca2+ sensitivity of
contraction and decreased maximal force in reconstituted cardiac
muscle fibers (Chang and Potter, 2005; Mirza et al., 2005; Willott
et al., 2010), but is in agreement with previous studies by our
group and others (Chang et al., 2005; Mirza et al., 2005, 2007).
The possibility of the effects of E54K on actomyosin ATPase
assays being an artifact or miscalculation is ruled out based on
its agreement with other groups’ results, and the fact that SDS-
PAGE analysis shows that E54K Tm is present, and the amount of
myosin is similar for all samples (Figure 2B).
Based on the sequence of Tm, and the crystal structures of Tm
fragments (Brown et al., 2001, 2005), the following interactions
may be affected by the mutations, and contributing to the differ-
ences in thermal stability. Themutation E40K occurs directly after
a very unstable region of the Tm, which has alanines, lysines and
serines in the a and d positions of the coiled coil interface, com-
prising a highly flexible region (Phillips, 1986). Like E40, E54 is an
external glutamate which is postulated by Phillips to be a “consen-
sus” actin binding residue (Phillips, 1986; Phillips et al., 1986). As
postulated, both mutations E40K and E54K have been shown to
reduce the affinity of Tm for actin, although at different thin fila-
ment states (On and Off states, respectively) (Mirza et al., 2007).
Based on the actomyosin ATPase assay Tm titration studies, rather
than substantially affecting the actin binding affinity (Mirza et al.,
2007), the mutations may be affecting the position of Tm on
actin itself, altering the blocked or open position of Tm on actin
(Orzechowski et al., 2014). Indeed, the two mutations have been
shown to affect the transition from weakly- to strongly-bound
crossbridges when reconstituted into muscle fibers from which
endogenous Tm was removed (Borovikov et al., 2009b, 2011).
In the case of E40K, the position of Tm on actin may be block-
ing more of the myosin interaction sites than ASWT and thereby
diminishing the baseline activity to a greater extent than ASWT.
Table 1 | Thermal transition temperatures of ASWT and mutants.
Mutant TM50 TM1 TM2 TM3 H1 H2 H3 ε1 ε2 ε3 n
Degrees celsius Kcal/Mol
ASWT 45.3±0.3 28.1±2.5 n/a 45.5±0.1 −22±8 n/a −144±29 0.38±0.03 n/a 0.64±0.04 9
E40K 44.0±0.2* 38.2±0.8‡ 43.9±0.2 51.8±1.0‡ −38±12 −146±36 −128±34 0.39±0.08 0.41±0.06 0.18± 0.05 9
E54K 45.3±0.1 37.8±0.6‡ 44.3±0.1 52.6±0.3‡ −36±10 −146±23 −118±22 0.39±0.07 0.36±0.06 0.24± 0.05 9
E62Q 47.9±0.5‡ 37.9±0.4‡ 45.1±0.1 51.5±1.0‡ −30±7 −149±64 −141±48 0.35±0.09 0.35±0.11 0.29±0.19 11
L185R 46.8±0.3* 30.4±1.9 n/a 46.5±0.1 −24±6 n/a −155±33 0.39±0.01 n/a 0.61±0.02 9
Shown are the results of thermal denaturation spectra fitted to a two and three-transition model (see methods for description). The values represent mean ± SE of
the values acquired from the fits. The melting temperature (TM50), transition temperatures (TM1, 2, 3), corresponding enthalpy values (H) and extinction coefficients
(ε) for each mutant are reported for the spectra measured the number of times shown (n). Statistical significance for temperatures were determined by ANOVA
followed by Dunnett’s multiple comparisons test; *p < 0.05, ‡p < 0.001.
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FIGURE 4 | The effects of DCM and HCM-associated mutations on the
side-chain interactions of Tm dimers. Side-chain interactions were
modeled by Sybyl, and compared with the corresponding wildtype (upper
half) for each mutation indicated. In all the panels the nitrogen atoms are blue
and the oxygen atoms are red. The helical chairs are depicted as ribbons,
with one chain of Tm in black and the other chain in gray.
The decrease in maximal activity was not seen in the previously
published myofibrillar ATPase assays (Chang et al., 2005), but
based on the Tn and TmATPase inhibition studies presented here,
obstruction of the myosin binding sites on actin likely exists, and
this effect may be diminished in myofibrils due to the more intact
nature of the system. In actomyosin ATPase assays, the effects
of Tm alone on actomyosin interaction are masked by the pres-
ence of Tn, which confers Ca2+ sensitivity and increases the rate
beyond the extent inhibited by Tm. In the case of E54K, Tn alone
does not fully regulate the actomyosin ATPase activity, as evi-
denced by the increased activity over ASWT (Figure 1A), which
is in agreement with another study, where increased cooperative
unit size of actin-Tm and actin-Tm-Tn caused by E54K, was con-
trasted to a decrease caused by E40K, despite comparative pheno-
type (Olson et al., 2001) and decreases in Ca2+ sensitivity in more
intact systems (Chang et al., 2005; Mirza et al., 2005). In a more
intact system such as inmyofibrils (Chang et al., 2005), where spa-
tial organization of the thick and thin filaments are maintained,
themutationmay be further diminishing the ATPase activity, pos-
sibly to the same extent of E40K, thus producing similar effects on
contractility.
The results of the thermal denaturation studies suggest that a
single point mutation does affect the global Tm structure, albeit
not the total helical content, but the melting transitions of the Tm
dimer itself. Characterization of these regions in Tm have shown
that a denaturation curve of Tm, like those shown in Figure 3,
is comprised of numerous overlapping melting transitions which
correspond to flexible sequences that are essential for actin bind-
ing (Greenfield and Hitchcock-Degregori, 1995). The lack of
significant differences in the secondary structure of Tm and the
local destabilizations found in the denaturation curves suggest
that the mutation induced alterations occur at the level of intra-
and inter-coil interactions rather than at the level of the whole
Tm dimer. However, when in complex with Tn, local instabilities
in Tm are known to have long-range effects on the overlapping
ends of Tm (Mamidi et al., 2013a,b). In conclusion, the findings
reported here show that the structural alterations in Tm observed,
may affect the position of Tmon actin, which in solutionmay alter
the inhibitory or activating states of the thin filament. The results
of the studies conducted suggest that in agreement with the wide
range of clinical phenotypes, the mutational effects on structure
and protein-protein interactions vary between and within disease
categories.
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